The story of the erectile dysfunction drug presents a intricate picture for shareholders. While the initial introduction generated substantial gains, the expiration of its exclusive rights opened the door to off-brand https://elodieoriq800269.blogdun.com/42518404/sildenafil-and-big-pharma-a-precarious-opportunity